ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
35 hedge funds and large institutions have $32.9M invested in Anthera Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
1.14%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$7.07M |
2 |
DM
2
Deerfield Management
New York
|
$6.43M |
3 |
O
3
OrbiMed
New York
|
$3.43M |
4 |
BI
4
BVF Inc
San Francisco,
California
|
$2.07M |
5 |
BC
5
Broadfin Capital
New York
|
$1.95M |
Top Sellers
No sellers this quarter